DiPole Materials, Inc. Announces Product Launch of Gelatin BioPapers for Tissue Engineering, 3D Bioprinting, and Drug Screening
DiPole Materials, Inc. announced today the launch of their first product line: BioPapers for use in tissue engineering, 3D bioprinting and drug screening.
BioPapers are made of gelatin nanofibers and then specially treated to provide a robust scaffold upon which to grow cells. BioPapers mimic the cell’s natural environment, overcoming the major drawback of cell culture plates and other synthetic environments that cause cells to grow in unwanted ways.
“Our customers needed a standardized scaffold that made cells behave like they do inside the human body. They were frustrated that the only available scaffolds were of synthetic materials which caused the cells to misbehave.” said Dr. Scott Gaboury, co-Founder and Chief Science Officer of DiPole Materials, Inc.
BioPapers are produced in DiPole Materials’ manufacturing facility in Baltimore. The facility is co-located with Harbor Designs & Manufacturing, LLC, a cGMP facility, making it easy for DiPole Materials to partner with medical device manufacturers as they advance their technologies into the clinic.
Based on intellectual property licensed from the Naval Research Laboratory, BioPapers were advanced from the lab to a commercial product thanks to funding from TEDCO’s Technology Validation Program. Investment from the Abell Foundation helped establish manufacturing capacity and brought BioPapers to commercial launch.
About DiPole Materials, Inc.: Dipole Materials is a custom manufacturer of high-performance fibers for today’s most innovative markets. DiPole Materials production facility is located at 1100 Wicomico Street and business operations are located at 8 Market Place in Baltimore, Maryland. For further information visit www.dipolematerials.com or contact Ken Malone at 410.692.8605.